Ken Moseley, Senior VP and General Counsel at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 11,700 shares at $20.10 ($235K) on 2016-09-23, disclosed to the SEC on 2016-09-23.
Open-market sale of $235k BLCM by Senior VP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BLCM | SELL | 2016-09-20 | $70K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $20K | — | Filing → |
| BLCM | SELL | 2016-06-06 | $195K | — | Filing → |